Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Kedudukan dalam Saham #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Harga Saham
$38.41
Modal Pasaran
$170.67B
Perubahan (1 hari)
1.17%
Perubahan (1 tahun)
-49.92%
Negara
DK
Perdagangan Novo Nordisk A/S (NVO)

Kategori

Sejarah harga saham bagi Novo Nordisk A/S (NVO)
Harga penutupan tertinggi: $38.35 pada 2026-03-01

Harga penutupan terendah: $28.10 pada 2007-07-01
Sejarah harga saham Novo Nordisk A/S dari 2007 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 17.70%
2025 -51.54%
2024 1.70%
2023 -23.31%
2022 17.33%
2021 57.90%
2020 22.89%
2019 26.29%
2018 -13.92%
2017 49.77%
2016 -37.97%
2015 26.27%
2014 24.70%
2013 10.84%
2012 43.58%
2011 6.03%
2010 -4.61%
2009 14.74%
2008 -41.68%
2007 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$465.49 -7.78%
US
$755.73 13.32%
US
$302.35 54.55%
BE
$99.21 -36.97%
AU
$703.96 16.36%
NL